Policymakers and U.S. health officials are looking to expand antibody testing for the new coronavirus as a way to provide key data that could allow them to reopen businesses and ease social distancing measures—but some experts warn that many of the tests are unregulated and often produce unreliable results.
Gov. Andrew Cuomo (D) on Thursday said the New York Department of Health this week will execute about 14,000 tests to identify whether individuals have built up antibodies to the new coronavirus, in today's bite-sized hospital and health industry news from New York, Washington, and West Virginia.
CMS on Monday announced that clinicians who participate in the Quality Payment Program's Merit-based Incentive Payment System can receive credit for participating in clinical trials testing potential Covid-19 treatments by reporting the activity and their findings, as the number of cases of Covid-19 in the United States surpassed 780,000.
Health experts say a variety of factors—including the potential to develop immunity, whether the virus' transmission becomes seasonal, adherence to social distancing measures, and more—will determine whether America faces a second wave of Covid-19 cases and how strong that wave could be.
We're now several months into the new coronavirus epidemic and there's still much uncertainty around the disease and how it affects patients. That's why Advisory Board's Alice Thornton Bell writes that it's imperative for providers to discuss care options, such as whether patients would want to go on a ventilator, with Covid-19 patients.